GLIOBLASTOMA (GBM)
Clinical trials for GLIOBLASTOMA (GBM) explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA (GBM) trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA (GBM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain cancer breakthrough? new drug trial targets aggressive tumors
Disease control Not yet recruitingThis study is testing a new drug called BGB-58067 for people newly diagnosed with a fast-growing brain cancer called glioblastoma. The main goals are to see if the drug can get into the brain tumor and if it helps patients live longer. Participants will take the drug along with s…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
First patients sought for groundbreaking brain cancer drug trial
Disease control Not yet recruitingThis is the first-ever study in people to test the safety and best dose of a new drug called MT-125 for glioblastoma, a fast-growing brain tumor. The drug is designed to be taken alongside standard radiation therapy to try to make the radiation work better. The study will enroll …
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1 • Sponsor: Myosin Therapeutics Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Brain cancer trial aims to zap tumors, spare healthy tissue
Disease control Not yet recruitingThis study is testing whether using a smaller radiation field after brain cancer surgery can control the tumor just as well as standard treatment while causing fewer side effects. It will involve 79 adults with glioblastoma who have recently had surgery. Participants will receive…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: NA • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New gene therapy aims to turn the body against deadly brain cancer
Disease control Not yet recruitingThis study is testing a new gene therapy called TGX-007 for people with a fast-growing type of brain cancer called glioblastoma. The therapy uses a harmless virus to deliver two treatments directly into the tumor: one to kill cancer cells and another to activate the patient's own…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1, PHASE2 • Sponsor: Trogenix ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New weapon tested against deadly brain cancers that Won't quit
Disease control Not yet recruitingThis is an early-stage study to test the safety and find the right dose of a new drug called FZ-AD005 for adults with aggressive brain tumors that have come back or stopped responding to standard treatments. The study will enroll about 40 people with high-grade gliomas, including…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE1 • Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test supercharged immune cells against deadly brain cancer
Disease control Not yet recruitingThis early-stage study is testing a new type of cell therapy for adults with glioblastoma that has come back after treatment. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back. The main goals are to see …
Matched conditions: GLIOBLASTOMA (GBM)
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New hope for fighting deadly brain tumors: experimental drug combo enters testing
Disease control Not yet recruitingThis study is testing whether adding a new oral drug called silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of aggressive brain cancer (glioblastoma) live longer without their cancer getting worse. It will involve about 162 newly diagnosed p…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
New 'Glow' microscope aims to sharpen Surgeons' view of brain tumors
Diagnosis Not yet recruitingThis study is testing a new digital camera accessory for a surgical microscope. It aims to help neurosurgeons see suspected aggressive brain tumors more clearly during surgery. The study will observe 37 patients in Europe to see if the new tool provides better image quality and v…
Matched conditions: GLIOBLASTOMA (GBM)
Sponsor: Leica Microsystems (Schweiz) AG • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
Scientists probe why brain cancer hits men harder
Knowledge-focused Not yet recruitingThis study aims to understand why glioblastoma, a severe brain cancer, is more common and aggressive in men. Researchers will analyze tumor and blood samples from 40 newly diagnosed patients to see if male hormones (androgens) influence the tumor's environment and the body's immu…
Matched conditions: GLIOBLASTOMA (GBM)
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 04, 2026 02:20 UTC
-
Researchers probe hidden mental toll of deadly brain cancer
Knowledge-focused Not yet recruitingThis study aims to understand the mental health challenges faced by people with glioblastoma, a serious brain cancer. Researchers will ask 176 adult patients in Germany to fill out questionnaires about depression, anxiety, suicidal thoughts, and quality of life. The goal is to id…
Matched conditions: GLIOBLASTOMA (GBM)
Sponsor: University Hospital, Essen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC